SCH-37370 是一种有效且具有口服活性的血小板活化因子和组胺双重拮抗剂。 Sch 37370 阻断 [3H]pyrilamine 与大鼠脑膜中组胺-H1 受体的结合。 Sch 37370 选择性地抑制 PAF 诱导的人血小板聚集（IC50：0.6 mM），并且还与 PAF 竞争与人肺膜制剂中特定位点的结合（IC50：1.2 mM）。

SCH-37370 is an effective and orally active dual antagonist of platelet-activating factor and histamine. Sch 37370 blocks the binding of [3H]pyrilamine to histamine-H1 receptors in rat brain membranes. Sch 37370 selectively inhibits PAF-induced aggregation of human platelets (IC50 : 0.6 mM) and also competes with PAF binding to specific sites in membrane preparations from human lungs (IC50 : 1.2 mM).

117796-52-8

C21H21ClN2O

352.86

乙酰地氯雷他定

DMSO:30 mg/ml (85.02 mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years